Molecular and Cellular Pharmacology Training Program
University of Wisconsin School of Medicine and Public Health

Eric Britigan, PhD

Position title: Account Manager II, Thermo Fisher Scientific, Madison, WI

Email: britigan@wisc.edu

Phone: Advisor: Dr. Beth Weaver

Address:
Graduation: 12/2015
Research Interest: The role of P19ARF in mitosis

Eric Britigan

Publications

  • Ryan SD, Britigan EM, Zasadil LM, Witte K, Audhya A, Roopra A, and Weaver BA., 2012, “Up-regulation of the mitotic checkpoint component Mad1 causes chromosomal instability and resistance to microtubule poisons,” Proc. Natl. Acad. Sci. U S A., 109:E2205-14. PMCID: PMC3421180
  • Zasadil LM, Britigan EM, and Weaver BA., 2013, “2n or not 2n: Aneuploidy, polyploidy and chromosomal instability in primary and tumor cells,” Semin. Cell Dev. Biol., 24:370-379. PMCID: PMC3736819
  • Britigan EM, Wan J, Zasadil LM, Ryan SD, and Weaver BA., 2014, “The ARF tumor suppressor prevents chromosomal instability and ensures mitotic checkpoint fidelity through regulation of Aurora B,” Mol. Biol. Cell, 15:2761-73. PMCID: PMC4161511
  • Zasadil LM, Britigan EM, Ryan SD, Kaur C, Guckenberger DJ, Beebe DJ, Moser AR, Weaver BA, “High rates of chromosome missegregation suppress tumor progression but do not inhibit tumor initiation,” Mol Biol Cell. 2016 Jul 1;27(13):1981-9. doi: 10.1091/mbc.E15-10-0747. Epub 2016 May 4. PMCID: PMC4927272.